Top

Quality of Life Research

Gepubliceerd in:

14-01-2020

Assessing health-related quality of life in cancer survivors: factors impacting on EORTC QLU-C10D-derived utility values

Auteurs: Thomas van Gelder, Brendan Mulhern, Dounya Schoormans, Olga Husson, Richard De Abreu Lourenço

Gepubliceerd in: Quality of Life Research | Uitgave 6/2020

Abstract

Purpose

To investigate the factors influencing EORTC QLQ-C30-derived EORTC QLU-C10D utility values across five cancer types (non-Hodgkin lymphoma, multiple myeloma, colorectal, thyroid, and prostate cancer) and a general population sample.

Methods

Data from the Dutch population-based patient-reported outcomes following initial treatment and long-term evaluation of survivorship (PROFILES) registry collected between 2009 and 2012 were used. EORTC QLQ-C30 data were used to estimate utility values by applying the EORTC QLU-C10D instrument using Australian utility weights. Regression analyses were conducted, within and across cancer type, to examine the factors influencing utility values, including patient- and cancer-specific factors, as well as the EORTC QLQ-C30 scale/item scores.

Results

The mean utility value for the total cancer sample was 0.791 (SD 0.201), significantly lower than that from the general population (0.865, SD 0.165). Multiple myeloma patients had the lowest utility value at 0.663 (SD 0.244). Physical functioning, pain and nausea and vomiting were the health-related quality of life (HRQoL) domains with the greatest impact on utility values; cognitive functioning and dyspnea had the lowest impact. Of the demographic and clinical factors, unemployment for reasons other than retirement, age older than 75 years, number of comorbidities, and experience of symptoms all had a statistically significant negative impact on utility values.

Conclusions

This study is one of the first to apply the EORTC QLU-C10D to a heterogeneous group of cancer patients. Results can be used to more efficiently target care towards factors influencing HRQoL. Furthermore, it enhances our understanding of how the EORTC QLU-C10D performs across cancer types, supporting its use in cost–utility analyses.

vorige artikel Whom should we ask? A systematic literature review of the arguments regarding the most accurate source of information for valuation of health states

volgende artikel Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework

Alleen toegankelijk voor geautoriseerde gebruikers

Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute,85(5), 365–376.CrossRef

Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,20(10), 1727–1736. https://doi.org/10.1007/s11136-011-9903-x.CrossRef

Sintonen, H., & Pekurinen, M. (1990s). A fifteen-dimensional measure of health-related quality of life (15D) and its applications. In S. R. Walker & R. M. Rosser (Eds.), Quality of life assessment: Key issues in the 1990s (pp. 185–195). Dordrecht: Springer.CrossRef

Brazier, J., Deverill, M., & Green, C. (1999). A review of the use of health status measures in economic evaluation. Journal of Health Services Research & Policy,4(3), 174–184. https://doi.org/10.1177/135581969900400310.CrossRef

Rowen, D., Young, T., Brazier, J., & Gaugris, S. (2012). Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research,15(8), 1059–1068. https://doi.org/10.1016/j.jval.2012.08.2201.CrossRef

Longworth, L., Yang, Y., Young, T., Mulhern, B., Hernández Alava, M., Mukuria, C., et al. (2014). Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: A systematic review, statistical modelling and survey. Health Technology Assessment (Winchester, England),18(9), 1–224. https://doi.org/10.3310/hta18090.CrossRef

Lorgelly, P. K., Doble, B., Rowen, D., & Brazier, J. (2017). Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,26(5), 1163–1176. https://doi.org/10.1007/s11136-016-1443-y.CrossRef

King, M. T., Costa, D. S. J., Aaronson, N. K., Brazier, J. E., Cella, D. F., Fayers, P. M., et al. (2016). QLU-C10D: A health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,25(3), 625–636. https://doi.org/10.1007/s11136-015-1217-y.CrossRef

Norman, R., Viney, R., Aaronson, N. K., Brazier, J. E., Cella, D., Costa, D. S. J., et al. (2016). Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,25(3), 637–649. https://doi.org/10.1007/s11136-015-1115-3.CrossRef

10.

King, M. T., Viney, R., Simon Pickard, A., Rowen, D., Aaronson, N. K., Brazier, J. E., et al. (2018). Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30. PharmacoEconomics,36(2), 225–238. https://doi.org/10.1007/s40273-017-0582-5.CrossRefPubMed

11.

Young, T., Yang, Y., Brazier, J. E., Tsuchiya, A., & Coyne, K. (2009). The first stage of developing preference-based measures: Constructing a health-state classification using Rasch analysis. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,18(2), 253–265. https://doi.org/10.1007/s11136-008-9428-0.CrossRef

12.

Rowen, D., Brazier, J., Young, T., Gaugris, S., Craig, B. M., King, M. T., et al. (2011). Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research,14(5), 721–731. https://doi.org/10.1016/j.jval.2011.01.004.CrossRef

13.

van de Poll-Franse, L. V., Horevoorts, N., van Eenbergen, M., Denollet, J., Roukema, J. A., Aaronson, N. K., et al. (2011). The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. European Journal of Cancer (Oxford, England: 1990),47(14), 2188–2194. https://doi.org/10.1016/j.ejca.2011.04.034.CrossRef

14.

de Rooij, B. H., Ezendam, N. P. M., Mols, F., Vissers, P. A. J., Thong, M. S. Y., Vlooswijk, C. C. P., et al. (2018). Cancer survivors not participating in observational patient-reported outcome studies have a lower survival compared to participants: The population-based PROFILES registry. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,27(12), 3313–3324. https://doi.org/10.1007/s11136-018-1979-0.CrossRef

15.

Mols, F., Husson, O., Oudejans, M., Vlooswijk, C., Horevoorts, N., & van de Poll-Franse, L. V. (2018). Reference data of the EORTC QLQ-C30 questionnaire: Five consecutive annual assessments of approximately 2000 representative Dutch men and women. Acta Oncologica (Stockholm, Sweden),57(10), 1381–1391. https://doi.org/10.1080/0284186X.2018.1481293.CrossRef

16.

Bergius, S., Torvinen, S., Muhonen, T., Roine, R. P., Sintonen, H., & Taari, K. (2017). Health-related quality of life among prostate cancer patients: Real-life situation at the beginning of treatment. Scandinavian Journal of Urology,51(1), 13–19. https://doi.org/10.1080/21681805.2016.1247293.CrossRefPubMed

17.

de Groot, S., Redekop, W. K., Versteegh, M. M., Sleijfer, S., Oosterwijk, E., Kiemeney, L., et al. (2018). Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,27(1), 115–124. https://doi.org/10.1007/s11136-017-1704-4.CrossRef

18.

Färkkilä, N., Torvinen, S., Roine, R. P., Sintonen, H., Hänninen, J., Taari, K., et al. (2014). Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,23(4), 1387–1394. https://doi.org/10.1007/s11136-013-0562-y.CrossRef

19.

Hagiwara, Y., Shiroiwa, T., Shimozuma, K., Kawahara, T., Uemura, Y., Watanabe, T., et al. (2018). Impact of adverse events on health utility and health-related quality of life in patients receiving first-line chemotherapy for metastatic breast cancer: Results from the SELECT BC study. PharmacoEconomics,36(2), 215–223. https://doi.org/10.1007/s40273-017-0580-7.CrossRefPubMed

20.

Meng, Y., McCarthy, G., Berthon, A., & Dinet, J. (2017). Patient-reported health state utilities in metastatic gastroenteropancreatic neuroendocrine tumours—An analysis based on the CLARINET study. Health and Quality of Life Outcomes,15(1), 131. https://doi.org/10.1186/s12955-017-0711-z.CrossRefPubMedPubMedCentral

21.

Torvinen, S., Färkkilä, N., Sintonen, H., Saarto, T., Roine, R. P., & Taari, K. (2013). Health-related quality of life in prostate cancer. Acta Oncologica (Stockholm, Sweden),52(6), 1094–1101. https://doi.org/10.3109/0284186X.2012.760848.CrossRef

22.

Craig, B. M., Reeve, B. B., Cella, D., Hays, R. D., Pickard, A. S., & Revicki, D. A. (2014). Demographic differences in health preferences in the United States. Medical care,52(4), 307–313. https://doi.org/10.1097/MLR.0000000000000066.CrossRefPubMedPubMedCentral

23.

Dolan, P. (1996). The effect of experience of illness on health state valuations. Journal of Clinical Epidemiology,49(5), 551–564.CrossRef

24.

Yeh, J. M., Hanmer, J., Ward, Z. J., Leisenring, W. M., Armstrong, G. T., Hudson, M. M., et al. (2016). Chronic conditions and utility-based health-related quality of life in adult childhood cancer survivors. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djw046.CrossRefPubMedPubMedCentral

25.

Leslie, H. S., Mary, K. G., & Christian, W. (2011). TNM classification of malignant tumours (7th ed.). New York: Wiley-Blackwell.

26.

Sangha, O., Stucki, G., Liang, M. H., Fossel, A. H., & Katz, J. N. (2003). The Self-Administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research. Arthritis and Rheumatism,49(2), 156–163. https://doi.org/10.1002/art.10993.CrossRefPubMed

27.

Rubin, D. B. (2011). Multiple imputation for nonresponse in surveys. Hoboken: Wiley.

28.

Azur, M. J., Stuart, E. A., Frangakis, C., & Leaf, P. J. (2011). Multiple imputation by chained equations: What is it and how does it work? MPR International Journal of Methods in Psychiatric Research,20(1), 40–49.CrossRef

29.

Raghunathan, T. E., Lepkowski, J. M., Van Hoewyk, J., & Solenberger, P. (2001). A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodology.,27(1), 85.

30.

Van Buuren, S. (2007). Multiple imputation of discrete and continuous data by fully conditional specification. Statistical Methods in Medical Research,16(3), 219.CrossRef

31.

Johnsen, A. T., Tholstrup, D., Petersen, M. A., Pedersen, L., & Groenvold, M. (2009). Health related quality of life in a nationally representative sample of haematological patients. European Journal of Haematology,83(2), 139–148. https://doi.org/10.1111/j.1600-0609.2009.01250.x.CrossRefPubMedPubMedCentral

32.

Mols, F., Oerlemans, S., Vos, A. H., Koster, A., Verelst, S., Sonneveld, P., et al. (2012). Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 year after diagnosis: Results from a population-based study using the PROFILES registry. European Journal of Haematology,89(4), 311–319. https://doi.org/10.1111/j.1600-0609.2012.01831.x.CrossRefPubMed

33.

Mols, F., Schoormans, D., Smit, J. W. A., Netea-Maier, R. T., Links, T. P., van der Graaf, W. T. A., et al. (2018). Age-related differences in health-related quality of life among thyroid cancer survivors compared with a normative sample: Results from the PROFILES Registry. Head & Neck,40(10), 2235–2245. https://doi.org/10.1002/hed.25325.CrossRef

34.

Oerlemans, S., Nijziel, M. R., & van de Poll-Franse, L. V. (2015). Age-related differences in quality of life among patients with diffuse large B-cell lymphoma. Cancer,121(16), 2857–2858. https://doi.org/10.1002/cncr.29427.CrossRefPubMed

35.

van der Poel, M. W. M., Oerlemans, S., Schouten, H. C., & van de Poll-Franse, L. V. (2015). Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: A study from the population-based PROFILES registry. Annals of Hematology,94(4), 651–661. https://doi.org/10.1007/s00277-014-2264-0.CrossRefPubMed

36.

Brazier, J., Ratcliffe, J., Salomon, J., & Tsuchiya, A. (2016). Measuring and valuing health benefits for economic evaluation (2nd ed.). Oxford, New York: Oxford University Press.CrossRef

37.

McTaggart-Cowan, H., King, M. T., Norman, R., Costa, D. S. J., Pickard, A. S., Regier, D. A., et al. (2019). The EORTC QLU-C10D: The Canadian valuation study and algorithm to derive cancer-specific utilities from the EORTC QLQ-C30. MDM policy & practice,4(1), 2381468319842532–2381468319842532. https://doi.org/10.1177/2381468319842532.CrossRef

38.

Norman, R., Mercieca-Bebber, R., Rowen, D., Brazier, J. E., Cella, D., Pickard, A. S., et al. (2019). U.K. utility weights for the EORTC QLU-C10D. Health Economics. https://doi.org/10.1002/hec.3950.CrossRefPubMed

39.

Kemmler, G., Gamper, E., Nerich, V., Norman, R., Viney, R., Holzner, B., et al. (2019). German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30. Quality of Life Research. https://doi.org/10.1007/s11136-019-02283-w.CrossRefPubMedPubMedCentral

40.

van de Poll-Franse, L. V., Mols, F., Gundy, C. M., Creutzberg, C. L., Nout, R. A., Verdonck-de Leeuw, I. M., et al. (2011). Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. European Journal of Cancer (Oxford, England: 1990),47(5), 667–675. https://doi.org/10.1016/j.ejca.2010.11.004.CrossRef

Titel: Assessing health-related quality of life in cancer survivors: factors impacting on EORTC QLU-C10D-derived utility values
Auteurs: Thomas van Gelder
Brendan Mulhern
Dounya Schoormans
Olga Husson
Richard De Abreu Lourenço
Publicatiedatum: 14-01-2020
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 6/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-020-02420-w

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2020

Patient acceptance and outcome of mental health screening in Swedish adults with cystic fibrosis

Oral health-related quality of life of patients after heart transplantation and those with heart failure is associated with general health-related quality of life: a cross-sectional study

Health-related quality of life (HRQoL) associated with echinococcosis patients in Tibetan communities in Shiqu County, China: a case–control study

Qualitative study of patients with venous malformations: symptom experiences and content validity of patient-reported outcome measures

The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease

Quality of life in people with dementia living in nursing homes: validation of an eight-item version of the QUALIDEM for intensive longitudinal assessment